MRSA

Sarasota, Florida, September 18, 2026 Lakewood-Amedex Biotherapeutics Inc. has announced that it has received central and all clinical-site Institutional...

Mesa, Arizona, U.S., September 14, 2026 Bright Path Labs, a U.S.-based pharmaceutical manufacturer, announced that the U.S. Food and...

Los Angeles, California, U.S., September 14, 2026 Armata Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has...

STATEN ISLAND, N.Y., August 14, 2026 Acurx Pharmaceuticals, Inc. reported its second-quarter 2026 financial results and provided a business...

WALTHAM, Mass., August 11, 2026 Innoviva Specialty Therapeutics (IST) announced that three of its infectious disease therapies, XACDURO® (sulbactam/durlobactam),...

Staten Island, New York, USA, August 10, 2026 Acurx Pharmaceuticals, Inc. has announced a new scientific partnership with Leiden...

LOS ANGELES, July 20, 2026 Armata Pharmaceuticals, Inc. has announced significant clinical, regulatory, manufacturing, and operational progress supporting the...

SARASOTA, Fla., July 15, 2026 Lakewood-Amedex Biotherapeutics Inc. has announced encouraging preclinical safety results supporting dose selection for the...

ROSWELL, Ga., DUBLIN, Ireland & HAMILTON, Bermuda, July 7, 2026 Saol Therapeutics has announced the resubmission of its New...

SARASOTA, Fla., July 7, 2026 Lakewood-Amedex Biotherapeutics has announced its support for the reintroduction of the bipartisan Pioneering Antimicrobial...